varenicline has been researched along with Benign Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Arcangeletti, M; Cox, JJ; Gossage, SJ; Haroun, R; Luiz, AP; Sikandar, S; Wood, JN; Zhao, J | 1 |
| Borderud, S; Cooley, ME; de León-Sanchez, S; Friedman, ER; Gonzalez, I; Holland, S; Hyland, KA; Irwin, KE; Kwon, D; Levy, DE; Malloy, L; Miller-Sobel, J; Muzikansky, A; O'Brien, M; Ostroff, JS; Park, ER; Partridge, AH; Perez, GK; Peterson, L; Pirl, WF; Ponzani, C; Rabin, J; Regan, S; Rigotti, NA; Sprunck, K; Temel, JS; Whitlock, CW | 1 |
| Hitsman, B; Jao, NC; Klass, E; Leone, F; May, JR; McCarter, K; Pearman, T; Schnoll, RA | 1 |
| Blazekovic, S; Carroll, AJ; Hitsman, B; Kalhan, R; Leone, FT; Schnoll, RA; Veluz-Wilkins, AK; Wileyto, EP | 1 |
| Bastian, J; Carroll, A; Crawford, G; Flitter, A; Hitsman, B; Jao, NC; Kalhan, R; Leone, F; Schnoll, R; Weisbrot, J | 1 |
| Carroll, AJ; Hitsman, B; Hole, A; Jao, NC; Kalhan, R; Langer, C; Leone, F; Lubitz, SF; Miele, A; Patel, J; Paul Wileyto, E; Schnoll, R; Veluz-Wilkins, A | 1 |
| Carroll, AJ; Hitsman, B; Kim, K; Leone, FT; Miele, A; Olonoff, M; Schnoll, RA | 1 |
| Bartholomew, P; Elwell, M; Radi, Z; Vogel, WM | 1 |
| Blazekovic, S; Brubaker, TR; Hitsman, B; Hole, A; Kalhan, R; Langer, C; Leone, F; Patel, J; Price, S; Schnoll, R; Veluz-Wilkins, A; Wileyto, EP | 1 |
| Grief, SN | 1 |
| Dautzenberg, B | 1 |
2 review(s) available for varenicline and Benign Neoplasms
| Article | Year |
|---|---|
Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma.
Topics: Animals; Benzazepines; Carcinogenicity Tests; Disease Models, Animal; Humans; Hydromorphone; Lipoma; Mutagenicity Tests; Neoplasms; Phentolamine; Piperidines; Pyrimidines; Pyrroles; Quinoxalines; Rats; Risk Assessment; Varenicline | 2013 |
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2011 |
4 trial(s) available for varenicline and Benign Neoplasms
| Article | Year |
|---|---|
Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial.
Topics: Aged; Bupropion; Cotinine; Counseling; Decision Support Techniques; Female; Humans; Male; Middle Aged; Motivational Interviewing; Neoplasms; Patient Satisfaction; Patient Selection; Saliva; Smoking; Smoking Cessation; Smoking Cessation Agents; Telephone; Temperance; Tobacco Use Cessation Devices; Varenicline | 2020 |
Cancer-related disease factors and smoking cessation treatment: Analysis of an ongoing clinical trial.
Topics: Adult; Counseling; Female; Humans; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Neoplasms; Nicotinic Agonists; Quality of Life; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2018 |
Predictors of Varenicline Adherence Among Cancer Patients Treated for Tobacco Dependence and its Association With Smoking Cessation.
Topics: Adult; Female; Humans; Male; Medication Adherence; Middle Aged; Neoplasms; Self Report; Smoking Cessation; Smoking Cessation Agents; Tobacco Smoking; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2019 |
A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence.
Topics: Adult; Benzazepines; Counseling; Female; Humans; Male; Medication Adherence; Middle Aged; Neoplasms; Nicotine; Smoking; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2019 |
5 other study(ies) available for varenicline and Benign Neoplasms
| Article | Year |
|---|---|
Chemogenetic Silencing of Na
Topics: Acute Pain; Animals; Cancer Pain; Ganglia, Spinal; Hyperalgesia; Mice; Mice, Transgenic; Neoplasms; Sensory Receptor Cells; Varenicline | 2023 |
Change in Health-Related Quality of Life Among Individuals With Cancer Undergoing Smoking Cessation Treatment Involving Varenicline.
Topics: Benzazepines; Humans; Neoplasms; Nicotinic Agonists; Quality of Life; Smoking Cessation; Treatment Outcome; Varenicline | 2021 |
Longitudinal associations between smoking and affect among cancer patients using varenicline to quit smoking.
Topics: Affect; Aged; Cigarette Smoking; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasms; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Cessation Agents; Varenicline | 2019 |
The use of varenicline to treat nicotine dependence among patients with cancer.
Topics: Adult; Benzazepines; Bupropion; Counseling; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
[Methods and results of smoking cessation in cancer smoker's].
Topics: Benzazepines; Bupropion; Humans; Neoplasms; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2012 |